106 reports of this reaction
1.3% of all PROPYLENE GLYCOL reports
#15 most reported adverse reaction
ASTHENOPIA is the #15 most commonly reported adverse reaction for PROPYLENE GLYCOL, manufactured by Alcon Laboratories, Inc.. There are 106 FDA adverse event reports linking PROPYLENE GLYCOL to ASTHENOPIA. This represents approximately 1.3% of all 8,103 adverse event reports for this drug.
Patients taking PROPYLENE GLYCOL who experience asthenopia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENOPIA is a less commonly reported adverse event for PROPYLENE GLYCOL, but still significant enough to appear in the safety profile.
In addition to asthenopia, the following adverse reactions have been reported for PROPYLENE GLYCOL:
The following drugs have also been linked to asthenopia in FDA adverse event reports:
ASTHENOPIA has been reported as an adverse event in 106 FDA reports for PROPYLENE GLYCOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENOPIA accounts for approximately 1.3% of all adverse event reports for PROPYLENE GLYCOL, making it a notable side effect.
If you experience asthenopia while taking PROPYLENE GLYCOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.